We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Board Approves International Harmonization Strategy
FDA Advisory Board Approves International Harmonization Strategy
October 16, 2006
The U.S. Food and Drug Administration (FDA) Advisory Committee for Pharmaceutical Science overwhelmingly approved the agencys strategy for developing new international harmonization approaches for drug development, but members expressed reservations about the development of new guidance to supplement the international standards.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor